Filter Results
:
(2,143)
Show Results For
-
All HBS Web
(4,545)
- People (16)
- News (1,465)
- Research (2,143)
- Events (3)
- Multimedia (130)
- Faculty Publications (1,503)
Show Results For
-
All HBS Web
(4,545)
- People (16)
- News (1,465)
- Research (2,143)
- Events (3)
- Multimedia (130)
- Faculty Publications (1,503)
Sort by
- 15 Sep 2009
- First Look
First Look: September 15
the director and the quality of the prior LBO experience. This effect is robust to the most likely alternative explanations and supports the idea that directors and social networks play an influential role...
View Details
Keywords:
Martha Lagace
- October 2013 (Revised January 2014)
- Supplement
Fred Khosravi and AccessClosure (B)
By: Richard G. Hamermesh and Lauren Barley
It was January 2013, and Fred Khosravi, chairman of the board of AccessClosure Inc., wondered what the new year had in store for him and AccessClosure, the company he founded in late 2002. Khosravi was cautiously optimistic—the Mountain View, California-based medical...
View Details
Keywords:
Medical Devices;
Vascular Closure Device;
Patent Litigation;
Patenting;
Biomedical Research;
Biotechnology;
Biotech;
Technological Innovation;
Patents;
Health Care and Treatment;
Biotechnology Industry;
United States;
California
Hamermesh, Richard G., and Lauren Barley. "Fred Khosravi and AccessClosure (B)." Harvard Business School Supplement 814-038, October 2013. (Revised January 2014.)
- 09 Sep 2014
- First Look
First Look: September 9
assessing the startup health care company's 2014 marketing plan. On December 31, 2013, Vaxess had obtained an exclusive license to a series of patents for a silk protein...
View Details
Keywords:
Sean Silverthorne
- 09 Dec 2014
- First Look
First Look: December 9
The survey showed, for instance, that 1) the highly educated, ambitious women and men of HBS don't differ much in terms of what they value and hope for in their lives and careers; 2) it simply isn't true...
View Details
Keywords:
Sean Silverthorne
- 01 Oct 2008
- Research & Ideas
How Much Time Should CEOs Devote to Customers?
business and the company's strategy. In a service business like Tesco's, the health of the brand depends heavily on the quality of the millions...
View Details
Keywords:
by John Quelch
- 2014
- Working Paper
Team Scaffolds: How Meso-Level Structures Support Role-based Coordination in Temporary Groups
By: Melissa A. Valentine and Amy C. Edmondson
This paper shows how meso-level structures support effective coordination in temporary groups. Prior research on coordination in temporary groups describes how roles encode individual responsibilities so that coordination between relative strangers is possible. We...
View Details
Keywords:
Fluid Personnel;
Team Scaffolds;
Team Effectiveness;
Role-based Coordination;
Multi-method;
Health Care and Treatment;
Analytics and Data Science;
Knowledge Use and Leverage;
Organizational Structure;
Outcome or Result;
Performance Effectiveness;
Groups and Teams;
Networks;
Behavior;
Balance and Stability;
Health Industry
Valentine, Melissa A., and Amy C. Edmondson. "Team Scaffolds: How Meso-Level Structures Support Role-based Coordination in Temporary Groups." Harvard Business School Working Paper, No. 12-062, January 2012. (Revised June 2014.)
- November 2010
- Case
Children's Hospital Boston (A)
By: Scott A. Snook and Jeffrey C. Connor
Five year old Matty died at Children's Hospital Boston as a result of elective neurosurgery to "cure" his epilepsy. The organizational system, not the surgery, had failed. During post-operative recovery, he experienced a prolonged seizure that resulted in his death....
View Details
Keywords:
Health Care and Treatment;
Leadership;
Managerial Roles;
Organizational Structure;
Management Systems;
Management Teams;
Health Industry
Snook, Scott A., and Jeffrey C. Connor. "Children's Hospital Boston (A)." Harvard Business School Case 411-041, November 2010.
- October 2013 (Revised April 2015)
- Case
Myomo: Getting Sales in Motion
By: Frank V. Cespedes, Shikhar Ghosh and Matthew Preble
In late 2012, the management team of Myomo, a startup which had designed a unique myoelectric arm brace for patients with dysfunctional arms, was deciding which of the three sales models the company had tested to pursue as its sales strategy going forward. Each model...
View Details
Keywords:
Technological Innovation;
Information Technology;
Marketing Strategy;
Decision Choices and Conditions;
Health Care and Treatment;
Business Startups;
Sales;
Growth and Development Strategy;
Health Industry;
Health Industry
Cespedes, Frank V., Shikhar Ghosh, and Matthew Preble. "Myomo: Getting Sales in Motion." Harvard Business School Case 814-034, October 2013. (Revised April 2015.)
- 08 Apr 2016
- Research & Ideas
How to Hire a Millennial
take a hard look at their mentorship programs, a widely embraced concept that now too often degenerates into pro forma and intermittent “check-in” lunches. More important, companies must offer clear pathways to real responsibility. The kidney dialysis and medical...
View Details
Keywords:
by Joseph Fuller
- 05 Mar 2013
- First Look
First Look: March 5
emerging Asian markets. Paper: http://www.asiabusinessinsights.com/articles.html#sub_articles_E-commerce_in_Asia Issuer Quality and Corporate Bond Returns Authors:Greenwood, Robin, and Samuel G. Hanson Publication:Review View Details
Keywords:
Sean Silverthorne
- 01 Jul 2021
- Office Hours
Readers Ask: Which Companies Are Transforming Work?
The COVID-19 pandemic accelerated workforce shifts that had been gaining momentum before the public health crisis, thrusting employers and workers into a new era within months. Joseph Fuller, a professor at Harvard Business School and...
View Details
- 03 Jul 2012
- First Look
First Look: July 3
details Schön Klinik's founding, its early focus on measurement and improvement, and the design and implementation of a system-wide structure for measuring and reporting actual health outcomes. The case...
View Details
Keywords:
Sean Silverthorne
- 29 Jul 2008
- First Look
First Look: July 29, 2008
situation facing Gary Gottlieb, president of Brigham and Women's Hospital (BWH), prior to the opening of BWH's integrated cardiovascular center. This case allows students to develop an appreciation View Details
Keywords:
Martha Lagace
- 09 Dec 2008
- First Look
First Look: December 9, 2008
roles that various constituencies played in the development process. Purchase the case: http://harvardbusinessonline.hbsp.harvard.edu/ b01/en/common/item_detail.jhtml?id=207027 Note on Accountability in the U.S. Health View Details
Keywords:
Martha Lagace
- 08 Jun 2010
- First Look
First Look: June 8
model for inflammatory bowel disease in 2001 and 2009, before and after the reorganization. The case can be used to examine health care provider strategy, integrated care...
View Details
Keywords:
Martha Lagace
- 12 Aug 2008
- First Look
First Look: August 12, 2008
http://hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=808138 Connectivity in Health Care Harvard Business School Note 307-047 This note describes the current state of...
View Details
Keywords:
Sean Silverthorne
- 12 Mar 2014
- Research & Ideas
Entrepreneurship and Multinationals Drive Globalization
War I, the management of political risk became a central concern for firms operating internationally. These risks were on many levels, from expropriation to exchange controls and other economic policies. The issue is explored in multiple...
View Details
- 29 Sep 2015
- First Look
September 29, 2015
multitude of complex problems plaguing the U.S. health system. The United States over the last 50 years has focused most of its health resources...
View Details
Keywords:
Sean Silverthorne
- Article
Biosimilars and Follow-On Products in the United States: Adoption, Prices, and Users
By: Ariel Dora Stern, Jacqueline L. Chen, Melissa Ouellet, Mark R. Trusheim, Zeid El-Kilani, Amber Jessup and Ernst R. Berndt
Biologic drugs account for a disproportionate share of the increase in pharmaceutical spending in the U.S. and worldwide. Against this backdrop, many look to the expanding market for biosimilars—follow-on products to biologic drugs—as a vehicle for controlling...
View Details
Keywords:
Pharmaceuticals;
Drug Spending;
Drug Pricing;
Health Care and Treatment;
Spending;
Price;
Markets;
Cost Management;
United States
Stern, Ariel Dora, Jacqueline L. Chen, Melissa Ouellet, Mark R. Trusheim, Zeid El-Kilani, Amber Jessup, and Ernst R. Berndt. "Biosimilars and Follow-On Products in the United States: Adoption, Prices, and Users." Health Affairs 40, no. 6 (June 2021): 989–999.
- 10 Jun 2014
- First Look
First Look: June 10
such as talent and capital, away from wealth creation and toward wealth distribution. It distorts thinking. Restoring the balance of power is critical to the competitiveness and the health View Details
Keywords:
Sean Silverthorne